Summary
This filing is an amendment (Amendment No. 1) to DexCom, Inc.'s Quarterly Report on Form 10-Q for the period ended March 31, 2011. The primary purpose of this amendment is to re-file Exhibit 10.26, an Amendment Number One to a Non-Exclusive Distribution Agreement with RGH Enterprises, Inc., dated March 29, 2011. Certain portions of this exhibit are subject to confidential treatment. Additionally, new certifications from the CEO and CFO, as required by Rule 12b-15 of the Securities Exchange Act of 1934, are included. This filing does not update the financial statements or other disclosures from the original Form 10-Q, but rather addresses specific SEC comments regarding exhibit confidentiality and certifications.
Financial Highlights
25 data pointsBeta
Financial Statements
Beta
| Revenue | $14.20M |
| Cost of Revenue | $9.06M |
| Gross Profit | $5.10M |
| R&D Expenses | $6.27M |
| SG&A Expenses | $10.72M |
| Operating Expenses | $17.00M |
| Operating Income | -$11.87M |
| Interest Expense | $6K |
| Net Income | -$11.80M |
| EPS (Basic) | $-0.05 |
Key Highlights
- 1This is an Amendment No. 1 to the Form 10-Q for the quarter ended March 31, 2011, focusing on exhibit re-filing and new certifications.
- 2Exhibit 10.26, an amendment to a distribution agreement with RGH Enterprises, Inc., is re-filed with portions subject to confidential treatment.
- 3New certifications from the Chief Executive Officer and Chief Financial Officer are included as required by Rule 12b-15.
- 4The amendment does not alter the financial statements or other disclosures made in the original Form 10-Q.
- 5DexCom, Inc. is identified as an accelerated filer.
- 6As of April 28, 2011, 62,400,466 shares of common stock were outstanding.
- 7The filing addresses specific SEC staff comments regarding the original Form 10-Q submission.
Frequently Asked Questions
The main reason for this filing is to respond to comments from the SEC staff regarding the original Form 10-Q. Specifically, it re-files Exhibit 10.26 (an amendment to a distribution agreement) with certain portions under confidential treatment and includes new certifications from the CEO and CFO as required by SEC rules.
No, this amendment does not change or restate the financial statements or any other disclosures from the original Form 10-Q filed for the period ended March 31, 2011. It is primarily an administrative filing to address exhibit and certification requirements.
Exhibit 10.26 is the Amendment Number One to a Non-Exclusive Distribution Agreement between RGH Enterprises, Inc. and DexCom, Inc., dated March 29, 2011. Parts of this agreement are being kept confidential.
Being an 'accelerated filer' means DexCom meets certain size and filing history requirements defined by the SEC. Typically, this indicates a larger, more established company with a history of timely SEC filings, which allows for certain reporting accommodations but also carries specific disclosure obligations.